Ziad W. Elmezayen

Ziad W. Elmezayen

Auto-generated profile, based on publicly available information

Ziad W. Elmezayen

Faculty of Medicine, Kafr Elsheikh University, Egypt

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2025 in Clinical Medicine Insights: Case Reports
Verified
Journal Article
Open access
ZEZiad W. Elmezayen
Ziad W. Elmezayen
ZMZeina Zakarya Marzouk
Zeina Zakarya Marzouk
MAMohammad Adi
Mohammad Adi
Introduction: Adult-Onset Still’s Disease (AOSD) is a rare inflammatory disease. It usually causes high fevers, joint pain, a fleeting rash, and very high ferritin levels. The symptoms can mimic infections, autoimmune disorders, or cancers, so it can be hard to diagnose. Liver involvement is common but usually mild. Severe hepatitis is rare. Case Presentation: We report a 24-year-old woman who had 3 weeks of daily high fevers, a temporary salmon-pink rash, sore throat, muscle pain, and joint pain. Her blood tests showed high white blood cells with mostly neutrophils, persistent monocytosis, severely elevated liver enzymes, and very high ferritin. Tests ruled out infections, autoimmune diseases, and cancers. She met criteria for AOSD, and her glycosylated ferritin was low. The patient responded rapidly to intravenous methylprednisolone, but relapsed with polyarthritis upon tapering, which resolved completely within 48 hours of initiating anakinra. Discussion: This case highlights the diagnostic challenges of AOSD presenting predominantly with hepatic involvement and atypical laboratory features such as persistent monocytosis. Recognition of extreme hyperferritinemia as a diagnostic clue can prevent delays in diagnosis. The dramatic response to IL-1 blockade underscores cytokine dysregulation as a central pathogenic mechanism. Conclusion: Clinicians should consider AOSD in patients with febrile hepatitis and extreme hyperferritinemia. Early initiation of biologic therapy targeting IL-1 can achieve rapid remission, improve quality of life, and prevent complication.

18 June 2026 in JTCVS Techniques
Verified
Journal Article
Open access
AWAhmed Wahba
Ahmed Wahba
ZEZiad W. Elmezayen
Ziad W. Elmezayen
OEOsama Elbahy
Osama Elbahy
MEMohamed N. Elshabrawi
Mohamed N. Elshabrawi
MEMohammed Ehmidat
Mohammed Ehmidat
Sameh M. SaidSameh M. Said
Sameh M. Said
The Ross procedure offers superior hemodynamics and growth potential for patients with unrepairable aortic valve disease, but pulmonary autograft dilation and progressive neoaortic valve regurgitation remain key limitations. Complete autograft reinforcement with Dacron has been proposed to enhance structural stability and prevent dilation. However, concerns persist regarding potential autograft distortion, impaired leaflet coaptation, and increased valve regurgitation. This systematic review and meta-analysis compares clinical outcomes of fully Dacron-supported versus unsupported or partially supported autografts in the Ross procedure. A comprehensive literature search of PubMed, Web of Science, Cochrane, and Scopus databases was conducted from inception through March 30, 2026. Five retrospective comparative cohort studies including a total of 526 patients met inclusion criteria. Outcomes evaluated were early mortality (≤30 days), overall survival, freedom from autograft reoperation, and incidence of moderate or greater neoaortic valve regurgitation. Pooled risk ratios (RRs) with 95% CIs were calculated using random-effects meta-analysis. No significant differences were observed between fully supported and unsupported/partially supported groups for early mortality (RR, 2.52; 95% CI, 0.28-22.51; P = .41, I 2 = 0%), overall survival (RR, 0.99; 95% CI, 0.97-1.00], P = .14, I 2 = 0%), freedom from autograft reoperation (RR, 0.90; 95% CI, 0.76-1.07], P = .25, I 2 = 79.1%), or incidence of moderate or greater neoaortic valve regurgitation (RR, 2.00; 95% CI, 0.39-10.25; P = .41, I 2 = 73.5%). Complete Dacron reinforcement of the pulmonary autograft does not increase the risk of neoaortic valve regurgitation or adversely affect clinical outcomes compared with unsupported or partially supported autografts. This technique offers a viable strategy to improve autograft durability and may enable the Ross procedure's application in patients previously deemed suboptimal candidates. Surgical technique should be tailored to individual patient profiles and institutional expertise, rather than standardized adoption of one technique.

18 March 2026 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ZEZiad W. Elmezayen
Ziad W. Elmezayen
MAMohammad Adi
Mohammad Adi
RERafeek Walid Elmezayen
Rafeek Walid Elmezayen
HYHe Yunting
He Yunting
ASAhmed H. Sharaf
Ahmed H. Sharaf
Furosemide is commonly used off-label in the neonatal intensive care unit to promote diuresis and improve pulmonary mechanics in preterm infants, but prolo

21 April 2026 in Clinical Medicine Insights: Case Reports
Verified
Journal Article
Open access
ZEZiad W. Elmezayen
Ziad W. Elmezayen
ZMZeina Zakarya Marzouk
Zeina Zakarya Marzouk
MAMohammad Adi
Mohammad Adi
Introduction: Systemic toxicity from topical epinephrine is rare because dermal and mucosal absorption is typically limited. However, application to highly vascular mucosa, particularly under occlusion, may result in clinically significant systemic absorption. Case presentation: A 42-year-old woman developed severe headache, palpitations, tremor, and marked hypertension shortly after a compounded 2.5% lidocaine with epinephrine (1:2000; 0.5 mg/mL) gel was applied to the labial mucosa under occlusion during a cosmetic procedure. An estimated 0.5 to 1.5 mg of epinephrine was applied. Symptoms began within 10 minutes and persisted until gel removal approximately 25 minutes later. On EMS arrival, heart rate was 145 bpm and blood pressure 210/110 mmHg. In the emergency department, ECG showed sinus tachycardia without ischemic changes; laboratory studies were unremarkable except for mild respiratory alkalosis, and serial high-sensitivity troponin I was negative. Management included prompt removal of the topical agent, supportive care, and cardiac monitoring. Symptoms resolved spontaneously without pharmacologic intervention, and the patient was discharged after 4 hours of observation. Conclusion: Topical epinephrine applied to highly vascular mucosal surfaces—especially under occlusion—can rarely cause systemic sympathomimetic toxicity characterized by hypertension, tachycardia, tremor, and anxiety. Although it may resemble local anesthetic systemic toxicity, it is clinically distinct. Careful dosing, avoidance of occlusive dressings, close monitoring, and immediate removal of the agent at the first sign of systemic effects are essential to prevent complications.

22 April 2026 in Clinical Medicine Insights: Endocrinology and Diabetes
Verified
Journal Article
Open access
ZEZiad W. Elmezayen
Ziad W. Elmezayen
FQFarah Qrareya
Farah Qrareya
AAAbdallah Abdallah
Abdallah Abdallah
HSHossam Salameh
Hossam Salameh
WQWaheed Qaisi
Waheed Qaisi
Euthyroid sick syndrome (ESS) is characterized by abnormal thyroid function tests, most notably a low triiodothyronine (T3) level, occurring in the absence of intrinsic thyroid disease. A 54-year-old woman presented to the endocrinology clinic with a 4-month history of progressive fatigue, lethargy, and new-onset cold intolerance after initiation of semaglutide for weight management. The dose was titrated monthly over 4 months, during which she experienced significant weight loss of 22 kg. Laboratory evaluation revealed a thyroid function profile classic for ESS, with low free T3, low-normal free T4, and a normal thyroid-stimulating hormone (TSH) level that was inappropriately low relative to the reduced T3. After exclusion of primary thyroid and pituitary disorders, a diagnosis of ESS secondary to the catabolic state induced by rapid weight loss was made. The patient was counseled that this represented a physiological adaptation rather than intrinsic thyroid disease. Semaglutide was continued given its metabolic benefits, and nutritional optimization with adequate caloric and protein intake was advised.

8 June 2026 in Oxford Medical Case Reports
Verified
Journal Article
Open access
ZEZiad W Elmezayen
Ziad W Elmezayen
ESEnas Samara
Enas Samara
AZAlaa Zayed
Alaa Zayed
THTujan Hamed
Tujan Hamed
Thrombotic Thrombocytopenic Purpura (TTP) is a rare but potentially life-threatening thrombotic microangiopathy that presents significant diagnostic and therapeutic difficulties during pregnancy due to overlap with conditions like HELLP syndrome and preeclampsia. We present the case of a previously healthy 28-year-old woman at 34 weeks of gestation presenting with fatigue, headache, and petechiae. Laboratory tests indicated anemia, thrombocytopenia, increased lactate dehydrogenase levels, and the presence of schistocytes in the peripheral smear. Low ADAMTS13 activity (<10%) confirmed TTP. The patient showed significant improvement after receiving corticosteroids and undergoing daily plasma exchange. For maternal stability, an elective caesarean section was performed at 36 weeks, resulting in good maternal and neonatal outcomes. Early detection requires the timely diagnosis of unexplained thrombocytopenia, hemolysis, and neurologic symptoms in the absence of hypertension or abnormal coagulation, which should prompt immediate ADAMTS13 testing. Diagnosis and treatment were guided by multidisciplinary management and ADAMTS13 testing, resulting in complete remission without relapsing at the six-week follow-up.